Toshiba Infinix-i System Displays Radiation Dose Exposure to Improve Patient Safety

  Toshiba Infinix-i System Displays Radiation Dose Exposure to Improve Patient

         Dose Tracking and Spot Fluoroscopy Showcased at HRS and SCAI

Heart Rhythm 2013 SCAI 2013

Business Wire

TUSTIN, Calif. -- May 08, 2013

Providing clinicians real time data to optimize radiation dose management
during cardiac procedures, Toshiba America Medical Systems, Inc. introduces
the FDA-cleared Dose Tracking System for Infinix^TM-i cardiovascular X-ray.
The Dose Tracking System visualizes X-ray emissions like never before through
an easy-to-read color-coded display.

“We partnered with Toshiba to develop the Dose Tracking System to further
improve the safety and well-being of patients during interventional
procedures,” said Dr. Neil Dashkoff, clinical professor of medicine,
University at Buffalo; director, Cardiac Catheterization Laboratory, Erie
County Medical Center. “This user-friendly Dose Tracking System assists the
operator to ‘spread the skin dose,’ minimizing the risk of deterministic skin
injury to any given area. This is particularly important during long
interventional procedures and in circumstances where the patient may return to
the cath lab within a few months of the incident procedure.”

Toshiba’s Dose Tracking System displays an approximation of patient skin dose
on an intuitive and easy to interpret color-coded indicator presented as a
graphical representation of the patient that can be monitored in real time
throughout the exam.

“Through our partnership with the University at Buffalo, Toshiba designed the
Dose Tracking System as a visual aid, enabling clinicians to monitor patient
radiation exposure levels with an anatomical reference,” said Shuzo Yamamoto,
senior vice president, Toshiba.

The Dose Tracking System is the latest addition to the Infinix-i’s robust dose
management package.

Spot Fluoroscopy is another Infinix-i dose management technology, offering a
more complete picture while improving safety during interventional procedures.
It provides improved imaging while better managing radiation exposure by
providing a live “spot” of fluoroscopy overlaid onto the Last Image Hold (LIH)
surrounding area.

Both technologies will be showcased at the Heart Rhythm Society’s (HRS) annual
meeting (Booth #418) in Denver, and the Society for Cardiovascular Angiography
and Interventions (SCAI) annual meeting (Booth #1310) in Orlando, Fla., both
May 8—11, 2013.

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS)
markets, sells, distributes and services radiology and cardiovascular systems,
including CT, MR, ultrasound, X-ray and cardiovascular equipment, and
coordinates clinical diagnostic imaging research for all modalities in the
United States. For more information, visit the TAMS website at

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical
diagnostic imaging systems and comprehensive medical solutions, such as CT,
X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as
information systems for medical institutions. Toshiba Medical Systems
Corporation has been providing medical products for over 80 years. Toshiba
Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a world-leading diversified manufacturer, solutions provider and
marketer of advanced electronic and electrical products and systems. Toshiba
Group brings innovation and imagination to a wide range of businesses: digital
products, including LCD TVs, notebook PCs, retail solutions and MFPs;
electronic devices, including semiconductors, storage products and materials;
industrial and social infrastructure systems, including power generation
systems, smart community solutions, medical systems and escalators &
elevators; and home appliances.

Toshiba was founded in 1875, and today operates a global network of more than
550 consolidated companies, with 202,000 employees worldwide and annual sales
surpassing 6.1 trillion yen (US$74 billion). Visit Toshiba’s website at


Toshiba America Medical Systems, Inc.
Rachel Stuht, 714-669-7623
Michael Stewart, 310-295-3323
Press spacebar to pause and continue. Press esc to stop.